AQNEURSA (LEVACETYLLEUCINE) — FDA Approval NDA219132 (INTRABIO)
AQNEURSA (LEVACETYLLEUCINE) — FDA Approval NDA219132 (INTRABIO) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AQNEURSA; Active ingredients: LEVACETYLLEUCINE; Application number: NDA219132.
| Brand name | AQNEURSA |
|---|---|
| Active ingredients | LEVACETYLLEUCINE |
| Application number | NDA219132 |
| Sponsor | INTRABIO |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20240924 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →